1. Home
  2. BOLT vs LGCB Comparison

BOLT vs LGCB Comparison

Compare BOLT & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • LGCB
  • Stock Information
  • Founded
  • BOLT 2015
  • LGCB 2011
  • Country
  • BOLT United States
  • LGCB Japan
  • Employees
  • BOLT N/A
  • LGCB N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • LGCB
  • Sector
  • BOLT Health Care
  • LGCB
  • Exchange
  • BOLT Nasdaq
  • LGCB Nasdaq
  • Market Cap
  • BOLT 16.8M
  • LGCB 15.9M
  • IPO Year
  • BOLT 2021
  • LGCB 2023
  • Fundamental
  • Price
  • BOLT $5.65
  • LGCB $2.31
  • Analyst Decision
  • BOLT Buy
  • LGCB
  • Analyst Count
  • BOLT 3
  • LGCB 0
  • Target Price
  • BOLT $50.00
  • LGCB N/A
  • AVG Volume (30 Days)
  • BOLT 20.2K
  • LGCB 7.0K
  • Earning Date
  • BOLT 08-12-2025
  • LGCB 07-03-2025
  • Dividend Yield
  • BOLT N/A
  • LGCB N/A
  • EPS Growth
  • BOLT N/A
  • LGCB N/A
  • EPS
  • BOLT N/A
  • LGCB N/A
  • Revenue
  • BOLT $3,638,000.00
  • LGCB $8,993,265.00
  • Revenue This Year
  • BOLT N/A
  • LGCB N/A
  • Revenue Next Year
  • BOLT $24.14
  • LGCB N/A
  • P/E Ratio
  • BOLT N/A
  • LGCB N/A
  • Revenue Growth
  • BOLT N/A
  • LGCB N/A
  • 52 Week Low
  • BOLT $5.20
  • LGCB $1.22
  • 52 Week High
  • BOLT $15.60
  • LGCB $57.05
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 47.50
  • LGCB 47.44
  • Support Level
  • BOLT $5.68
  • LGCB $2.25
  • Resistance Level
  • BOLT $6.40
  • LGCB $2.55
  • Average True Range (ATR)
  • BOLT 0.27
  • LGCB 0.12
  • MACD
  • BOLT 0.07
  • LGCB -0.01
  • Stochastic Oscillator
  • BOLT 50.00
  • LGCB 31.43

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

Share on Social Networks: